Literature DB >> 22442345

DNGR-1 is a specific and universal marker of mouse and human Batf3-dependent dendritic cells in lymphoid and nonlymphoid tissues.

Lionel F Poulin1, Yasmin Reyal, Heli Uronen-Hansson, Barbara U Schraml, David Sancho, Kenneth M Murphy, Ulf K Håkansson, Luis Ferreira Moita, William W Agace, Dominique Bonnet, Caetano Reis e Sousa.   

Abstract

Mouse CD8α(+) dendritic cells (DCs) in lymphoid organs and CD103(+) CD11b(-) DCs in nonlymphoid tissues share phenotypic and functional similarities, as well as a unique shared developmental dependence on the transcription factor Batf3. Human DCs resembling mouse CD8α(+) DCs in phenotype and function have been identified in human blood, spleen, and tonsil. However, it is not clear whether such cells are also present in human nonlymphoid organs, and their equivalence to mouse CD8α(+) DC has recently been questioned. Furthermore, the identification of "CD8α(+) DC-like" cells across different tissues and species remains problematic because of the lack of a unique marker that can be used to unambiguously define lineage members. Here we show that mouse CD8α(+) DCs and CD103(+) CD11b(-) DCs can be defined by shared high expression of DNGR-1 (CLEC9A). We further show that DNGR-1 uniquely marks a CD11b(-) human DC population present in both lymphoid and nonlymphoid tissues of humans and humanized mice. Finally, we demonstrate that knockdown of Batf3 selectively prevents the development of DNGR-1(+) human DCs in vitro. Thus, high expression of DNGR-1 specifically and universally identifies a unique DC subset in mouse and humans. Evolutionarily conserved Batf3 dependence justifies classification of DNGR-1(hi) DCs as a distinct DC lineage.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22442345     DOI: 10.1182/blood-2012-01-406967

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  101 in total

1.  Enriched Cd141+ DCs in the joint are transcriptionally distinct, activated, and contribute to joint pathogenesis.

Authors:  Mary Canavan; Alice M Walsh; Vipul Bhargava; Sarah M Wade; Trudy McGarry; Viviana Marzaioli; Barry Moran; Monika Biniecka; Hannah Convery; Siobhan Wade; Carl Orr; Ronan Mullan; Jean M Fletcher; Sunil Nagpal; Douglas J Veale; Ursula Fearon
Journal:  JCI Insight       Date:  2018-12-06

2.  Dendritic cells: actin a dangerous part.

Authors:  Yvonne Bordon
Journal:  Nat Rev Immunol       Date:  2012-04-25       Impact factor: 53.106

3.  Differential use of autophagy by primary dendritic cells specialized in cross-presentation.

Authors:  Justine D Mintern; Christophe Macri; Wei Jin Chin; Scott E Panozza; Elodie Segura; Natalie L Patterson; Peter Zeller; Dorothee Bourges; Sammy Bedoui; Paul J McMillan; Adi Idris; Cameron J Nowell; Andrew Brown; Kristen J Radford; Angus Pr Johnston; Jose A Villadangos
Journal:  Autophagy       Date:  2015       Impact factor: 16.016

Review 4.  The Dr. Jekyll and Mr. Hyde complexity of the macrophage response in disease.

Authors:  Danielle Y F Twum; Lauren Burkard-Mandel; Scott I Abrams
Journal:  J Leukoc Biol       Date:  2017-02-13       Impact factor: 4.962

5.  Genetic vaccines to potentiate the effective CD103+ dendritic cell-mediated cross-priming of antitumor immunity.

Authors:  Yi Zhang; Guo Chen; Zuqiang Liu; Shenghe Tian; Jiying Zhang; Cara D Carey; Kenneth M Murphy; Walter J Storkus; Louis D Falo; Zhaoyang You
Journal:  J Immunol       Date:  2015-05-13       Impact factor: 5.422

Review 6.  Dendritic cells: arbiters of immunity and immunological tolerance.

Authors:  Kanako L Lewis; Boris Reizis
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-08-01       Impact factor: 10.005

Review 7.  The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting.

Authors:  Miriam Merad; Priyanka Sathe; Julie Helft; Jennifer Miller; Arthur Mortha
Journal:  Annu Rev Immunol       Date:  2013       Impact factor: 28.527

Review 8.  Regional specialization within the intestinal immune system.

Authors:  Allan M Mowat; William W Agace
Journal:  Nat Rev Immunol       Date:  2014-09-19       Impact factor: 53.106

Review 9.  Innate and adaptive immune cells in the tumor microenvironment.

Authors:  Thomas F Gajewski; Hans Schreiber; Yang-Xin Fu
Journal:  Nat Immunol       Date:  2013-10       Impact factor: 25.606

Review 10.  Molecular regulation of dendritic cell development and function in homeostasis, inflammation, and cancer.

Authors:  Taylor T Chrisikos; Yifan Zhou; Natalie Slone; Rachel Babcock; Stephanie S Watowich; Haiyan S Li
Journal:  Mol Immunol       Date:  2018-03-15       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.